Platelet and Plasma Market Future Challenges and Industry Growth Outlook by 2020-2026

Platelet and Plasma Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

The global platelet and plasma market is projected to observe substantial growth over the coming years owing to the growing instances of chronic diseases across the world. In modern medical treatments, patients can be provided either a pint of blood or only the particular components present in the blood that are crucial for treating specific patients conditions. This approach is known as blood component treatment. The key advantage of this technique is that numerous patients can get more benefits through one pint of donated blood. This factor would play a key role in the overall industry expansion.

Request for a sample copy of this report @

In addition, the increasing investments towards the development of the healthcare infrastructure across a number of developing and developed economies would further impel the platelet and plasma market size over the coming years. In fact, according to the Invest India report, the Indian healthcare sector is estimated to reach $372 billion by the end of 2022, which comprises hospitals, medical tourism, diagnostics sectors.   

With respect to application, the industry is bifurcated into perioperative indications, hemophilia, coagulation factor deficiencies, thrombocytopenia, platelet function disorders, as well as other applications like thrombotic thrombocytopenic purpura, liver disease, and hemorrhage. Of these, in 2019, the perioperative indications accounted for about 15% industry share. Th segment is further slated to foresee momentous growth over the coming years owing to the growing number of invasive surgeries. During such surgical procedures, major amount of blood loss is seen in the patients, which needs to be compensated for with the help of transfusion of platelets.

With respect to the distribution channel, the market is categorized into ambulatory surgical centers, hospitals, and others. Among these segments, the ambulatory surgical centers segment is projected to expand at a CAGR of about 2.5% over the forecast timeframe. The segment is ascribed to the rising patient inclination towards ambulatory surgeries. Ambulatory surgeries offer quality treatment at very affordable rates, which are driving their demand among consumers worldwide.

On the regional forefront, in 2019, the Latin America platelet and plasma market held a crucial industry share that was valued at more than $460 million. Over the forthcoming years, the segment is expected to witness a remunerative growth trend owing to the increasing prevalence of diseases such as autoimmune disorder, and hemophilia. The growing cases various other infectious diseases and accidental injuries in the region would further complement the market outlook in the region.

Growing prevalence of deadly disorders like hemophilia in highly populated countries like India would likely foster the growth of the overall industry through the analysis time period. In fact, according to health experts, India, with approximately 200,000 cases, is likely the world’s second-largest in terms of hemophilia patients.

The competitive landscape of the platelet and plasma market is inclusive of players such as the Italian Red Cross, European Blood Alliance, Japanese Red Cross, Indian Red Cross, American Association of Blood Banks, Blood Centers of America, and America’s Blood Centers among others. 

Browse full table of contents (TOC) of this report @

Partial Chapter of the Table of Content 

Chapter 4.  Platelet and Plasma Market, By Component

4.1. Key segment trends

4.2. Platelets

4.2.1.  Market size, by region, 2015 – 2026 (USD Million)

4.3. Plasma

4.3.1.  Market size, by region, 2015 – 2026 (USD Million)

Chapter 5.  Platelet and plasma Market, By Application

5.1. Key segment trends

5.2. Hemophilia

5.2.1.  Market size, by region, 2015-2026 (USD Million)

5.3. Thrombocytopenia

5.3.1.  Market size, by region, 2015-2026 (USD Million)

5.4. Perioperative indications

5.4.1.  Market size, by region, 2015-2026 (USD Million)

5.5. Platelet function disorders

5.5.1.  Market size, by region, 2015-2026 (USD Million)

5.6. Other platelet applications

5.6.1.  Market size, by region, 2015-2026 (USD Million)

5.7. Coagulation factor deficiencies

5.7.1.  Market size, by region, 2015-2026 (USD Million)

5.8. Thrombotic thrombocytopenic purpura

5.8.1.  Market size, by region, 2015-2026 (USD Million)

5.9. Hemorrhage

5.9.1.  Market size, by region, 2015-2026 (USD Million)

5.10.  Liver disease

5.10.1.   Market size, by region, 2015-2026 (USD Million)

5.11.  Other plasma applications

5.11.1.   Market size, by region, 2015-2026 (USD Million)